Granted Patent
B2
US 11,939,329 · App. 18/099,770 · Granted Mar 26, 2024
PARP1 inhibitors and uses thereof
Inventors:
Robert L. Hoffman (San Diego, CA); Porino Jinjo Va (San Diego, CA); Joseph Robert Pinchman (San Diego, CA); Lynnie Trzoss (San Diego, CA); Qing Dong (San Diego, CA); Stephen W. Kaldor (Foster City, CA)
Assignee:
XinThera, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Described herein are PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer.
Claims (9)
1. A compound selected from the group consisting of:
or a pharmaceutically acceptable salt thereof.
2. A pharmaceutical composition comprising a compound of claim 1 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient.
3. The compound of claim 1 that is
or a pharmaceutically acceptable salt thereof.
4. The compound of claim 1 that is
or a pharmaceutically acceptable salt thereof.
5. The compound of claim 1 that is
or a pharmaceutically acceptable salt thereof.
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jan 30, 2023
From: HOFFMAN, ROBERT L.; VA, PORINO JINJO; PINCHMAN, JOSEPH ROBERT; TRZOSS, LYNNIE; DONG, QING
To: XINTHERA, INC.
Reel/Frame 062526/0715 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jan 30, 2023
From: KALDOR, STEPHEN W.
To: XINTHERA, INC.
Reel/Frame 062526/0764 →
Continuity (3)
Provisional Application
63376338
· Sep 20, 2022
Provisional Application
63301907
· Jan 21, 2022
Cited By (2)